Literature DB >> 17095791

Word limits best explain failings of industry supported meta-analyses.

Jonathan J Deeks.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17095791      PMCID： PMC1635572          DOI： 10.1136/bmj.39024.372662.1F

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review.

Authors:  Anders W Jørgensen; Jørgen Hilden; Peter C Gøtzsche
Journal:  BMJ       Date:  2006-10-06

2.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

Review 3.  Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Authors:  Jonathan J Deeks; Lesley A Smith; Matthew D Bradley
Journal:  BMJ       Date:  2002-09-21

Review 4.  Celecoxib for rheumatoid arthritis.

Authors:  S Garner; D Fidan; R Frankish; M Judd; B Shea; T Towheed; G Wells; P Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2002
  4 in total
  4 in total

1.  Authors' reply on Cochrane reviews v industry supported meta-analyses.

Authors:  Anders W Jørgensen; Peter C Gøtzsche; Jørgen Hilden
Journal:  BMJ       Date:  2006-11-18

2.  Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.

Authors:  Nirav R Shah; J B Jones; Jaclyn Aperi; Rachel Shemtov; Anita Karne; Jeff Borenstein
Journal:  Obstet Gynecol       Date:  2008-05       Impact factor: 7.661

3.  Methodological quality of meta-analyses on treatments for chronic obstructive pulmonary disease: a cross-sectional study using the AMSTAR (Assessing the Methodological Quality of Systematic Reviews) tool.

Authors:  Robin S T Ho; Xinyin Wu; Jinqiu Yuan; Siya Liu; Xin Lai; Samuel Y S Wong; Vincent C H Chung
Journal:  NPJ Prim Care Respir Med       Date:  2015-01-08       Impact factor: 2.871

4.  Characteristics and Methodological Quality of Meta-Analyses on Hypertension Treatments-A Cross-Sectional Study.

Authors:  Xin Yin Wu; Xin Jian Du; Robin S T Ho; Clarence C Y Lee; Benjamin H K Yip; Martin C S Wong; Samuel Y S Wong; Vincent C H Chung
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-06       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.